Both HLF and NFIL3 share the same DNA binding motif and are involved in regulation of circadian rhythms, cell death, and drug metabolism, with HLF acting as a transcriptional enhancer (oncogene) and NFIL3 as a transcriptional repressor (and sometimes tumor suppressor). This evidence concerns the gene HLF and neoplasm.